Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
Entasis Therapeutics Holdings Inc. (ETTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2022 |
4
| Wagner Kristie Ann (VP, Principal Fin & Acct Off) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Disposed/sold 80,500 shares
@ $0
Disposed of 73,400 options to buy
@ $2.4, valued at
$176.2k
|
|
| 07/11/2022 |
4
| Triola Anna Diaz (Chief Commercial Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Disposed/sold 125,000 shares
@ $0
Disposed of 100,000 options to buy
@ $2.49, valued at
$249k
|
|
| 07/11/2022 |
4
| Tommasi Ruben (Chief Scientific Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Unknown transaction of 39,596 shares
@ $2.2, valued at
$87.1k
Disposed/sold 150,000 shares
@ $0
Disposed of 98,700 options to buy
@ $2.44, valued at
$240.8k
Disposed of 50,000 options to buy
@ $4.94, valued at
$247k
Disposed of 24,858 options to buy
@ $3.11, valued at
$77.3k
Disposed of 6,465 options to buy
@ $3.74, valued at
$24.2k
|
|
| 07/11/2022 |
4
| Ronsheim Matthew (Chief of Pharma Sciences & MFG) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Unknown transaction of 17,572 shares
@ $2.2, valued at
$38.7k
Disposed/sold 150,000 shares
@ $0
Disposed of 33,333 options to buy
@ $2.44, valued at
$81.3k
Disposed of 20,000 options to buy
@ $2.86, valued at
$57.2k
Disposed of 15,000 options to buy
@ $4.7, valued at
$70.5k
Disposed of 20,000 options to buy
@ $4.8, valued at
$96k
|
|
| 07/11/2022 |
4
| Perros Manoussos (President and CEO) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Unknown transaction of 56,072 shares
@ $2.2, valued at
$123.4k
Disposed/sold 478,500 shares
@ $0
Disposed of 325,755 options to buy
@ $2.44, valued at
$794.8k
Disposed of 145,000 options to buy
@ $4.94, valued at
$716.3k
Disposed of 183,013 options to buy
@ $3.11, valued at
$569.2k
Disposed of 69,970 options to buy
@ $3.74, valued at
$261.7k
|
|
| 07/11/2022 |
4
| Mueller John Patrick (Chief Development Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Unknown transaction of 17,092 shares
@ $2.2, valued at
$37.6k
Disposed/sold 150,000 shares
@ $0
Disposed of 75,698 options to buy
@ $2.44, valued at
$184.7k
Disposed of 50,000 options to buy
@ $4.94, valued at
$247k
Disposed of 25,092 options to buy
@ $3.11, valued at
$78k
Disposed of 18,253 options to buy
@ $3.74, valued at
$68.3k
|
|
| 07/11/2022 |
4
| Meek David D. (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Unknown transaction of 22,000 shares
@ $2.2, valued at
$48.4k
Disposed/sold 27,500 shares
@ $2.2, valued at
$60.5k
Disposed of 17,307 options to buy
@ $2.44, valued at
$42.2k
Disposed of 11,000 options to buy
@ $2.98, valued at
$32.8k
|
|
| 07/11/2022 |
4
| Mayer Howard (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Unknown transaction of 22,000 shares
@ $2.2, valued at
$48.4k
Disposed/sold 27,500 shares
@ $2.2, valued at
$60.5k
Disposed of 12,500 options to buy
@ $2.44, valued at
$30.5k
Disposed of 11,000 options to buy
@ $2.98, valued at
$32.8k
|
|
| 07/11/2022 |
4
| Keiley Elizabeth M (General Counsel) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Unknown transaction of 17,572 shares
@ $2.2, valued at
$38.7k
Disposed/sold 150,000 shares
@ $0
Disposed of 20,833 options to buy
@ $2.44, valued at
$50.8k
Disposed of 50,000 options to buy
@ $2.94, valued at
$147k
|
|
| 07/11/2022 |
4
| HASTINGS DAVID C (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Unknown transaction of 22,000 shares
@ $2.2, valued at
$48.4k
Disposed/sold 27,500 shares
@ $2.2, valued at
$60.5k
Disposed of 26,583 options to buy
@ $2.44, valued at
$64.9k
Disposed of 11,000 options to buy
@ $2.98, valued at
$32.8k
|
|
| 07/11/2022 |
4
| Berger Heather A. (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Unknown transaction of 22,000 shares
@ $2.2, valued at
$48.4k
Disposed/sold 27,500 shares
@ $2.2, valued at
$60.5k
Disposed of 17,307 options to buy
@ $2.44, valued at
$42.2k
Disposed of 11,000 options to buy
@ $2.98, valued at
$32.8k
|
|
| 07/11/2022 |
4
| Altarac David (Chief Medical Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Unknown transaction of 17,572 shares
@ $2.2, valued at
$38.7k
Disposed/sold 150,000 shares
@ $0
Disposed of 92,307 options to buy
@ $2.44, valued at
$225.2k
Disposed of 50,000 options to buy
@ $4.94, valued at
$247k
|
|
| 02/25/2022 |
4
| Wagner Kristie Ann (VP, Principal Fin & Acct Off) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 02/25/2022 |
3
| Wagner Kristie Ann (VP, Principal Fin & Acct Off) has filed a Form 3 on Entasis Therapeutics Holdings Inc. |
| 02/23/2022 |
4
| Innoviva, Inc. (10% Owner) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Acquired options to buy
@ $1.48, valued at
$0
Acquired options to buy
@ $1.48, valued at
$0 |
|
| 02/15/2022 |
4
| Tommasi Ruben (Chief Scientific Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Disposed/sold 22,816 options to buy
@ $4.98, valued at
$113.6k
Granted 15,210 options to buy
@ $2.44, valued at
$37.1k
Disposed/sold 15,632 options to buy
@ $6.85, valued at
$107.1k
Granted 12,024 options to buy
@ $2.44, valued at
$29.3k
Disposed/sold 50,411 options to buy
@ $15, valued at
$756.2k
Granted 28,006 options to buy
@ $2.44, valued at
$68.3k
Disposed/sold 56,500 options to buy
@ $5.66, valued at
$319.8k
Granted 43,460 options to buy
@ $2.44, valued at
$106k
|
|
| 02/15/2022 |
4
| Gutch Michael (See Remarks) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Disposed/sold 30,006 options to buy
@ $6.85, valued at
$205.5k
Granted 23,081 options to buy
@ $2.44, valued at
$56.3k
Disposed/sold 15,956 options to buy
@ $15, valued at
$239.3k
Granted 8,863 options to buy
@ $2.44, valued at
$21.6k
Disposed/sold 56,500 options to buy
@ $5.66, valued at
$319.8k
Granted 43,460 options to buy
@ $2.44, valued at
$106k
|
|
| 02/15/2022 |
4
| Ronsheim Matthew (See Remarks) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Disposed/sold 40,000 options to buy
@ $5.12, valued at
$204.8k
Granted 33,333 options to buy
@ $2.44, valued at
$81.3k
|
|
| 02/15/2022 |
4
| Perros Manoussos (President and CEO) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Disposed/sold 87,462 options to buy
@ $4.98, valued at
$435.6k
Granted 58,307 options to buy
@ $2.44, valued at
$142.3k
Disposed/sold 166,623 options to buy
@ $6.85, valued at
$1.1M
Granted 128,531 options to buy
@ $2.44, valued at
$313.6k
Disposed/sold 79,698 options to buy
@ $15, valued at
$1.2M
Granted 44,276 options to buy
@ $2.44, valued at
$108k
Disposed/sold 123,500 options to buy
@ $5.66, valued at
$699k
Granted 95,000 options to buy
@ $2.44, valued at
$231.8k
|
|
| 02/15/2022 |
4
| Mueller John Patrick (Chief Development Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Disposed/sold 22,816 options to buy
@ $4.98, valued at
$113.6k
Granted 15,210 options to buy
@ $2.44, valued at
$37.1k
Disposed/sold 16,892 options to buy
@ $6.85, valued at
$115.7k
Granted 12,993 options to buy
@ $2.44, valued at
$31.7k
Disposed/sold 7,265 options to buy
@ $15, valued at
$109k
Granted 4,035 options to buy
@ $2.44, valued at
$9.8k
Disposed/sold 56,500 options to buy
@ $5.66, valued at
$319.8k
Granted 43,460 options to buy
@ $2.44, valued at
$106k
|
|
| 02/15/2022 |
4
| Mayer Howard (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Disposed/sold 15,000 options to buy
@ $6.44, valued at
$96.6k
Granted 12,500 options to buy
@ $2.44, valued at
$30.5k
|
|
| 02/15/2022 |
4
| Meek David D. (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Disposed/sold 15,000 options to buy
@ $6.12, valued at
$91.8k
Granted 11,538 options to buy
@ $2.44, valued at
$28.2k
Disposed/sold 7,500 options to buy
@ $6.12, valued at
$45.9k
Granted 5,769 options to buy
@ $2.44, valued at
$14.1k
|
|
| 02/15/2022 |
4
| Behanna Heather (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Disposed/sold 15,000 options to buy
@ $5.66, valued at
$84.9k
Granted 11,538 options to buy
@ $2.44, valued at
$28.2k
Disposed/sold 7,500 options to buy
@ $6.12, valued at
$45.9k
Granted 5,769 options to buy
@ $2.44, valued at
$14.1k
|
|
| 02/15/2022 |
4
| Altarac David (Chief Medical Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Disposed/sold 120,000 options to buy
@ $5.7, valued at
$684k
Granted 92 options to buy
@ $2.44, valued at
$225.2 |
|
| 02/15/2022 |
4
| HASTINGS DAVID C (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Disposed/sold 12,060 options to buy
@ $6.85, valued at
$82.6k
Granted 9,276 options to buy
@ $2.44, valued at
$22.6k
Disposed/sold 15,000 options to buy
@ $5.66, valued at
$84.9k
Granted 11,538 options to buy
@ $2.44, valued at
$28.2k
Disposed/sold 7,500 options to buy
@ $6.12, valued at
$45.9k
Granted 5,769 options to buy
@ $2.44, valued at
$14.1k
|
|
| 02/15/2022 |
4
| Keiley Elizabeth M (General Counsel) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Disposed/sold 25,000 options to buy
@ $6.9, valued at
$172.5k
Granted 20,833 options to buy
@ $2.44, valued at
$50.8k
|
|
| 01/19/2022 |
4
| Tommasi Ruben (Chief Scientific Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 125,000 shares
@ $0 |
|
| 01/19/2022 |
4
| Gutch Michael (See Remarks) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 125,000 shares
@ $0 |
|
| 01/19/2022 |
4
| Ronsheim Matthew (See Remarks) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 125,000 shares
@ $0 |
|
| 01/19/2022 |
4
| Perros Manoussos (See Remarks) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 125,000 shares
@ $0 |
|
| 01/19/2022 |
4
| Mueller John Patrick (Chief Development Officer) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 125,000 shares
@ $0 |
|
| 01/19/2022 |
4
| Mayer Howard (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 27,500 shares
@ $0 |
|
| 01/19/2022 |
4
| Behanna Heather (Director) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Granted 27,500 shares
@ $0 |
|
|
|
|